article Open AccessTop 1% cited
Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials
Cancer · 2009 · Vol. 115(6) · pp. 1234–1244
Andreas du Bois✉(Helios Dr. Horst Schmidt Kliniken Wiesbaden)Alexander Reuß(Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe)Eric Pujade‐Lauraine(Hôtel-Dieu de Paris)Philipp Harter(Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe)Isabelle Ray‐Coquard(Centre Léon Bérard)Jacobus Pfisterer(University Hospital Schleswig-Holstein)
Abstract
The goal of primary surgery should be complete resection. The prognostic impact of tumor biology seemed to be partially overruled by residual tumor and further evaluation of biologic factors should stratify for residual tumor.
Ovarian cancer diagnosis and treatmentIntraperitoneal and Appendiceal MalignanciesEndometrial and Cervical Cancer TreatmentsMedicineTaxaneDebulkingOncologyOvarian cancerInternal medicineStage (stratigraphy)ChemotherapyMultivariate analysisRandomized controlled trial
MeSH terms
AdultAgedAged, 80 and overAntineoplastic Combined Chemotherapy ProtocolsFemaleHumansMiddle AgedOvarian NeoplasmsPrognosisSurvival AnalysisTreatment OutcomePaclitaxelPlatinum CompoundsNeoplasm, ResidualDisease-Free Survival
Citations
1,581
FWCI
50.12
field-weighted impact
References
37
Percentile
100%
vs. same field & year
Citations per year
Cited by
Epithelial ovarian cancer: Evolution of management in the era of precision medicine
CA A Cancer Journal for Clinicians · 2019 · 1,454 citations
CA125 and Ovarian Cancer: A Comprehensive Review
Cancers · 2020 · 584 citations
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration
PLoS Medicine · 2012 · 1,021 citations
Survival impact of complete cytoreduction to no gross residual disease for advanced-stage ovarian cancer: A meta-analysis
Gynecologic Oncology · 2013 · 421 citations
Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Annals of Oncology · 2013 · 1,110 citations
ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease
Annals of Oncology · 2019 · 1,130 citations
References
Cancer Statistics, 2006
CA A Cancer Journal for Clinicians · 2006 · 5,336 citations
The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume Stage III epithelial ovarian cancer: A gynecologic oncology group study
Gynecologic Oncology · 1992 · 553 citations
Complete Cytoreductive Surgery Is Feasible and Maximizes Survival in Patients with Advanced Epithelial Ovarian Cancer: A Prospective Study
Gynecologic Oncology · 1998 · 515 citations
Surgery in Recurrent Ovarian Cancer: The Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR Trial
Annals of Surgical Oncology · 2006 · 418 citations
What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?
Gynecologic Oncology · 2006 · 628 citations
Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-Analysis
Journal of Clinical Oncology · 2002 · 2,313 citations
A Randomized Clinical Trial of Cisplatin/Paclitaxel Versus Carboplatin/Paclitaxel as First-Line Treatment of Ovarian Cancer
JNCI Journal of the National Cancer Institute · 2003 · 1,126 citations
Estimates of the cancer incidence and mortality in Europe in 2006
Annals of Oncology · 2007 · 4,041 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.